Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Owlstone Medical bolsters management team

Chris Hodkinson, Dr Marc van der Schee and Hamilton Scanlon join

- PMLiVE

Vectura’s Flutiform flunks phase III COPD test

But new AirFluSal data demonstrates superior patient adherence over GSK’s Seretide/Advair

Novartis day

Novartis claims first place for its biosimilar Enbrel in US

However, Amgen’s patent infringement lawsuit could delay the launch of Erelzi

- PMLiVE

Chameleon launches Central London office

The agency’s European president Stephen Marchant will head up the new location

- PMLiVE

imc appoints London and Toronto managing directors

Graeme Reay and Dr Azhar Rana join the med comms agency

Shire Basingstoke

Shire launches dry eye drug Xiidra in US

Sparks rivalry with Allergan’s blockbuster Restasis as first new dry eye treatment in 13 years

- PMLiVE

Better together?

The future of ‘partnership’ in healthcare is with the crowd

Apps as medical devices – UK regulator updates its guidance

MHRA moves to help firms' health apps comply with its rules

- PMLiVE

Takeda: No decision yet on shutdown of Cambridge, UK unit

Tells PMLiVE that consultation over proposed closure of R&D site still ongoing

- PMLiVE

Joe Tardibuono joins HealthSTAR Communications

Brings experience from FCB Health and Forest Laboratories

- PMLiVE

Life appoints Sophie Gibbs

She joins the UK creative comms agency as a senior account manager

Novartis day

Novartis drug works in secondary progressive MS

Orally-active siponimod reduces risk of disability progression

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links